Foresite Capital Management III, LLC current holdings: Foreign ADRs
Foresite Capital Management III, LLC reported $0.00 billion in depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), 1 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are Akari Therapeutics, PLC.
- Akari Therapeutics, PLC: Country of operation —; Class SPONSORED ADR; Shares 197,072; Value $1,677,000.
Form 13F-HR as filed (SEC CIK 1645157): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||